Eléments de l'association

	Jean-Louis Montastruc	18
	Lévodopa	223
	Jean-Louis Montastruc *Sauf* Lévodopa"	14
	Lévodopa *Sauf* Jean-Louis Montastruc"	219
	Jean-Louis Montastruc Et Lévodopa	4
	Jean-Louis Montastruc Ou Lévodopa	237
	*Corpus*	2807

List of bibliographic references

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
000224	Santiago Perez-Lloret [France] ; Maria Veronica Rey [France] ; Nelly Fabre [France] ; Fabienne Ory [France] ; Umberto Spampinato [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France]	Do Parkinson's disease patients disclose their adverse events spontaneously?
000937	Jean-Louis Montastruc [France] ; Agnès Sommet [France] ; Pascale Olivier [France] ; Haieh Bagheri [France] ; Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Christine Brefel-Courbon [France] ; Joachim Ferreira [Portugal] ; Laurent Schmitt [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France]	Médicaments, maladie de Parkinson et syndromes parkinsoniens : actualités de pharmacovigilance
000D70	Olivier Rascol [France] ; Pierre Payoux [France, Portugal] ; Fabienne Ory [France] ; Joaquim J. Ferreira [France] ; Christine Brefel-Courbon [France] ; Jean-Louis Montastruc [France]	Limitations of current Parkinson's disease therapy. Discussion
001048	Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024